awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q45729167-2E6C2294-755E-4E4C-B839-2F1A450508A6
Q45729167-2E6C2294-755E-4E4C-B839-2F1A450508A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45729167-2E6C2294-755E-4E4C-B839-2F1A450508A6
Inimitable Imatinib: the range of targeted tumours expands to include T-cell lymphoma.
P2860
Q45729167-2E6C2294-755E-4E4C-B839-2F1A450508A6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45729167-2E6C2294-755E-4E4C-B839-2F1A450508A6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
88ddd12a44825b278a1798234f3d4b23297e09a0
P2860
Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR-ABL inhibitors as first-line therapy.